Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

Financials

SEC Filings

Filing date Form Description View
10-K

Annual report which provides a comprehensive overview of the company for the past year

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML

 

Anchor Link for Quarterly Results

Data provided by Kaleidoscope.